![CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG](https://dailymed.nlm.nih.gov/dailymed/image.cfm?name=Highlights+2.jpg&id=461352)
CARDENE(R) I.V. (NICARDIPINE HYDROCHLORIDE) PREMIXED INJECTION IN 4.8% DEXTROSE 20mg IN 200mL (0.1mg/mL) 200mL BAG
![Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension](https://www.ahajournals.org/cms/asset/77f334ca-523e-4249-8487-4309858bc123/hypertensionaha.120.16402.fig05.jpg)
Comprehensive Comparative Effectiveness and Safety of First-Line β-Blocker Monotherapy in Hypertensive Patients | Hypertension
![Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias](https://scielo.isciii.es/img/revistas/pharmacy/v8n1/original6_t2.gif)
Comparación del cumplimiento de las guías para fallo cardíaco crónico sistólico en dos clínicas ambulatorias
![Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/67c0797707e78e220989e461b8072db79ed1fb0a/5-Table1-1.png)
Table 1 from Tolerability and Feasibility of Beta-Blocker Titration in HFpEF Versus HFrEF: Insights From the CIBIS-ELD Trial. | Semantic Scholar
![Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure | Journal of the American Heart Association Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/d15e3063-0ec8-42b1-b8af-d20f381e66ff/jah36384-fig-0002.png)
Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure | Journal of the American Heart Association
![Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio Tratamiento con betabloqueantes en pacientes con disfunción sistólica ventricular pulmonar obstructiva crónica en medio ambulatorio](https://scielo.isciii.es/img/revistas/pharmacy/v7n4/205-212_03.gif)